Inoviq Ltd (IIQ)

Currency in AUD
0.180
+0.010(+5.88%)
Closed·
Trading near 52-week Low
IIQ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.1650.180
52 wk Range
0.1650.565
Key Statistics
Bid/Ask
0.17 / 0.18
Prev. Close
0.18
Open
0.17
Day's Range
0.165-0.18
52 wk Range
0.165-0.565
Volume
237.53K
Average Volume (3m)
397.38K
1-Year Change
-53.8462%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IIQ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.700
Upside
+288.89%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.700
(+288.89% Upside)

Earnings

Latest Release
Aug 26, 2026
EPS / Forecast
-0.03 / --
Revenue / Forecast
1.1M / --
EPS Revisions
Last 90 days

IIQ Income Statement

Compare IIQ to Peers and Sector

Metrics to compare
IIQ
Peers
Sector
Relationship
P/E Ratio
−3.4x18.4x−0.3x
PEG Ratio
−0.390.010.00
Price/Book
1.3x1.5x2.6x
Price / LTM Sales
11.4x1.0x3.0x
Upside (Analyst Target)
288.9%27.8%53.8%
Fair Value Upside
Unlock19.2%8.6%Unlock

INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an immunoaffinity magnetic bead-based isolation system for exosome isolation from plasma, serum, urine, saliva and cell-conditioned medium. It also offers non-invasive diagnostics using its proprietary exosome development technologies for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia.

Employees
15
Market
Australia

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
6.49M4.61%1.17M
Other Institutional Investors
29.38M20.87%5.29M
Public Companies & Retail Investors
104.91M74.52%18.88M
Total
140.78M100.00%25.34M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Tian An Medicare Limited10.15%14,285,7142,571
Merchant Funds Management Pty Ltd6.19%8,714,4451,569

FAQ

What Is the Inoviq (IIQ) Stock Price Today?

The Inoviq stock price today is 0.180 AUD.

What Stock Exchange Does Inoviq Trade On?

Inoviq is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Inoviq?

The stock symbol for Inoviq is "IIQ."

What Is the Inoviq Market Cap?

As of today, Inoviq market cap is 25.340M AUD.

What Is Inoviq's Earnings Per Share (TTM)?

The Inoviq EPS (TTM) is -0.057.

From a Technical Analysis Perspective, Is IIQ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Inoviq Stock Split?

Inoviq has split 5 times.

How Many Employees Does Inoviq Have?

Inoviq has 15 employees.

What is the current trading status of Inoviq (IIQ)?

As of Sep 12, 2026, Inoviq (IIQ) is trading at a price of 0.180 AUD, with a previous close of 0.180 AUD. The stock has fluctuated within a day range of 0.165 AUD to 0.180 AUD, while its 52-week range spans from 0.165 AUD to 0.565 AUD.

What Is Inoviq (IIQ) Price Target According to Analysts?

The average 12-month price target for Inoviq is 0.700 AUD, with a high estimate of 0.7 AUD and a low estimate of 0.7 AUD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +288.89% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.